All past events

6 Nov. 2019, 8:00

How much is too much - Excessive Pharmaceutical Prices in European Competition Law & Regulation

Join the debate on excessive pricing of pharmaceuticals!

» Read more

6 Sept. 2019

CeBIL Annual Symposium 2019: Legal Innovation to Support the Development of Antimicrobial Drugs

This symposium explores the complex interactions between law and antimicrobial research and development

» Read more

12 June 2019, 8:30

CeBIL – RIBS Symposium: At the Cutting Edge: New Developments in the Law of Biomedicine

Symposium aims to address contemporaneous issues emerging in the field of biomedicine

» Read more

27 May 2019, 9:00

Governing Health 4.0: Legal and Ethical Considerations – US-European Perspectives

Five international scholars from a multidisciplinary background will share their insights and debate on this topic.

» Read more

8 May 2019, 12:00-13:00

Regulatory and intellectual property aspects of orphan drug innovation

What are the possibilities and hindrances in the European IPR and regulatory system for the continued development of orphan drugs?

» Read more

30 Apr. 2019, 12:00-13:00

Lunch Seminar with Prof. Ana Santos Rutschman

Topic: Healthcare Blockchain Infrastructure: A U.S. Case Study.

» Read more

26 Apr. 2019, 16:15-18:00

Hvordan arbejder det juridiske fakultet på at forbedre dit helbred?

Mange spændende opfindelser kommer fra universiteternes forskere. Men hvordan bliver opfindelser transformeret til et produkt som den danske befolkning kan bruge?

» Read more

4 Mar. 2019, 9:00

Scientific, Regulatory & Legal Dimensions of Recent Advances in Gene Editing

Join us at an exciting CeBIL/CORS seminar on 4 March 2019 featuring gene-editing pioneer Feng Zhang from the Broad Institute, as well as legal and regulatory experts.

» Read more

20 Nov. 2018, 12:00-13:00

Lunch Seminar with Prof. Frederic Bouder

Risk communication in the 21st century: challenges and opportunities ahead.

» Read more

2 Nov. 2018, 10:00-13:00

Public Health Investment Protection and Policy

An outline of the legal developments leading up to the most recent decisions related to investment protection in the pharmaceutical industry and the legal challenges arising from these issues.

» Read more

Warning